We are a group of thought leaders and researchers within the drug delivery industry, committed to improving patient health through innovation and collaboration.
Joined February 2018
- Tweets75
- Following89
- Followers114
- Likes296
Great session @IAmBiotech. Thank you @RobinRoberts, "We are defined by what we have overcome." Very powerful and moving keynote. xitter.cf/IAmBiotech/status/1004…
Well done @Flexintl and @common_sensing! #DrugDelivery #Diabetes #Insulin xitter.cf/Flexintl/status/100259…
.@common_sensing, Flex partner to redesign digital insulin pen sensor. (via @DrugDeliveryNow) drugdeliverybusiness.com/com… #meddevice #MedicalDevices #MedTech
Congrats @Novartis! #oncology #healthcare #biopharma #cancer #innovation xitter.cf/Novartis/status/991418…
BREAKING: The @US_FDA has approved our first-in-class #CARTcell therapy for a second indication. #NovartisNews bit.ly/2rdLLLv
Well done. @Adherium Announces Program with @VitalusHealth on #WorldAsthmaDay globenewswire.com/news-relea… #asthma #COPD
SteadyMed's stock rockets, leads premarket gainers after United Therapeutics buyout deal on.mktw.net/2r9vjvX.Congrats @SMTheraputics #drugdelivery #UnitedTheraputics
Congrats @AbbVie. #AbbVie Submits Biologics License Application to U.S. FDA for Plaque #Psoriasis Treatment #Risankizumab prn.to/2HLMHBg #drugdelivery #biopharma
Congrats @boehringerus and @HealthPrize . "Patients who participated in the program showed an 85% decrease in gap days between refilling their next prescription" #drugdelivery #asthma #COPD xitter.cf/boehringerus/status/98…
Excited to announce that we expanded our RespiPoints program with @Healthprize to include people prescribed our COPD or asthma medicines! RespiPoints rewards people for learning about their condition & helps them take medication as prescribed
More: bit.ly/2HpBFBn
Drug Delivery Forum retweeted
New medicines offer hope to the 7 million+ affected by Alzheimer's. Read the report for more: onphr.ma/2HKqVLO #GoBoldly
Amazon has shelved a plan to sell drugs to hospitals, and insiders say there are two reasons why cnb.cx/2J0lzvi
Drug Delivery Forum retweeted
.@cnnhealth: Ovarian cancer vaccine shows promising results in human study. cnn.com/2018/04/11/health/ov…
Drug Delivery Forum retweeted
Release: Tandem Diabetes Care Announces Preliminary First Quarter 2018 Results tandemdiabetes.com/about-us/… #tslimX2 #tflex #tconnect $TNDM
Drug Delivery Forum retweeted
"Emotional blousing means you know what the outcome is going to be — a blood sugar low – but you cannot stop yourself. You cannot stand to see the high number stay there.” -- Suzanne Ghiloni, Joslin Educator #insulinstacking #dblog bit.ly/2GN7S23
Thank you @IPOtweet for this insight on recent biotech activity. nasdaq.com/article/big-biote… #healthcare #investing #biotech xitter.cf/IPOtweet/status/983495…
Big biotech swings: 2016 IPO AveXis pops 82% and 2018 IPO Menlo drops 77% dlvr.it/QP05Rn $AVXS $MNLO
Congrats @Glooko and Russ Johannesson. “Russ joins Glooko to build on recent patient, provider and payer growth with both economic and clinical outcomes”. #diabetes #drugdelivery xitter.cf/GlookoInc/status/98377…
Thrilled to welcome #healthcare #technology veteran Russ Johannesson to Glooko! #diabetes #DigitalHealth glooko.com/press-release/hea…
Congrats @Novartis and @AveXisInc. "If approved, AVXS-101 would be a first-in-class one-time therapy that addresses the root genetic cause of SMA by effectively replacing the defective SMN1 gene." #oncology #Healthinnovations xitter.cf/Novartis/status/983208…
#BreakingNews: We entered agreement to acquire @AveXisInc for USD 8.7 bn to transform care in #SMA and expand position as a gene therapy and #Neuroscience leader #NovartisNews
Drug Delivery Forum retweeted
They're Back! After Selling Kite, Belldegrun And Chang Seek To Change Cancer Treatment Again bit.ly/2Ip6gvO via @Forbes @matthewherper
Drug Delivery Forum retweeted
Despite Adverse Events, @US_FDA Panel Casts Positive Light on Blood Glucose Meters | #Regulatory Focus bit.ly/2EhieoI #FDA #meddevice #medtech
Congrats @AstraZeneca . "@US_FDA Approves BYDUREON for Use with Basal Insulin in Patients with Type 2 Diabetes with Inadequate Glycemic Control" #diabetes #drugdelivery #type2diabetes businesswire.com/news/home/2…
